Amid continuing market volatility and a slowdown in the Q4
HKEX reported 4Q2021 revenue of HK$4.73bn, -7.2% YoY and -10.9% QoQ. Shareholders’
net profit was HK$2.67bn, down 8.6% YoY, 17.8% QoQ, slightly below the consensus
estimates. Although 2021 started exceptionally well, 1Q2021 with record quarterly Headline
ADT of $224.4bn, 2Q2021 & 3Q2021 ADT both higher than the same period in 2020.
However, amid continuing market volatility in 2021 and a slowdown in 4Q2021. The ADT 4Q
has dropped to 126.4bn, down 24% YoY. In addition, Derivatives ADV decreased by 17% and
ADT of Northbound Trading of Stock Connect decreased by 20%, resulting in trading and
clearing fees decline in 4Q. Operating expenses decreased by 7.8% YoY, due to lower staff
expenses. This led to EBITDA margins broadly flat as 74%. The IPO pipeline remained very
robust, with the demand of US-listed Chinese companies homecoming listings in Hong Kong,
as well as the introduction of a listing regime for SPACs and the enhanced listing regime for
overseas issuers. However, numerous challenges posed by uncertainty surrounding the
continued inflationary pressure, the tightening of the Fed’s monetary policy, the entry of
interest rate hike cycle, ongoing geopolitical risks and the pandemic recovery.
2021 Annual Results
FY2021, revenue and other income of HK$20.95bn, up 9% against the previous record set in
2020. Profit attributable to shareholders up 9%, to a record high of HK$12.5bn. Core
business revenue of HK$20.1bn, up 10% compared with 2020, benefit from the headline
ADT set new record in 2021, reaching HK$166.7bn, up 29% YoY. Record Stock Connect
revenue and other income of HK$2.724bn, up 41% YoY. Stock Connect Northbound and
Southbound reached record annual turnover of RMB27.6 trillion and $9.3 trillion, up 31%
and 70% YoY, respectively, and record ADT of RMB120.1bn and $41.7bn, up 32 per cent and
71% YoY, respectively. Operating expenses increased by 2% compared with 2020, mainly
due to higher IT and computer maintenance expenses and higher product marketing
expenses and cash incentives for new products. EBITDA margin was 78%, 1 per cent higher
than 2020.
2021 review, with a total of 98 company listings raising HK$331.4bn, down from the strong
2020 (154 company listings raising HK$400.2bn) and 5% higher than 2019 (HK$314.2bn).
During the year, 59 new economy companies, including 31 Weighted Voting Rights (WVR),
healthcare and biotech firms (including Chapter 18A listings only) and/or secondary-listed
companies, accounting for 88% of IPO funds raised in Hong Kong during the period. Total
market turnover in 2021 reached HK$41.2 trillion, up 28% compared with 2020. Total
turnover of securitized derivatives (DWs, CBBCs and Inline Warrants) reached HK$4,956.8bn,
up 8% compared with 2020. As world metal trading remained under pressure, the
chargeable average daily volume of metals contracts traded on the LME decreased by 4%
from 2020
Important Information
This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.
By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.
The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.
Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.
This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.
Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.
Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.
Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.
To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.
The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.
This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.
This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.
IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE
Where the report contains research analyses or reports from a foreign research house, please note:
李浩然先生(Eric Li) 高級分析師 現任現為輝立証券持牌高級分析師,曾任職股票基金、家族辦公室及證券公司等,擁有多年的證券研究部門從業及投資經驗,並先後於香港最暢銷的財經媒體撰寫投資專欄。畢業於香港理工大學電子計算系。 Eric is currently a licensed research analyst at Phillip Securities. Prior to joining Phillip Securities, he has years of equity research and investment experiences in asset management company, family office and securities company. Meanwhile, he has written investment columns in Hong Kong`s best-selling financial media for years. He holds Bachelor of Arts in Computing from The Hong Kong Polytechnic University.